DEC 01, 2020 1:28 PM PST

CBD Does Not Effect Driving Ability, THC Wears Off in 4 Hours

WRITTEN BY: Annie Lennon

Researchers from the Lambert Initiative at the University of Sydney, have found that cannabidiol, a medically active compound found in cannabis, does not affect driving ability. They also found that moderate tetrahydrocannabinol (THC) intoxication leads to mild drivingimpairment that wears off within four hours. 

For the study, the researchers recruited 26 healthy participants at their testing site at Maastricht University in the Netherlands. Each were given four different types of cannabis with varying ratios of CBD and THC, including a placebo, at random to vaporize on four different occasions. 

Each participant's ability to drive was then assessed on the road in real-life conditions. Altogether, they drove 100 kilometers on a public highway in a dual-control car under the supervision of a driving instructor. 

To assess each particpant's driving, the researchers used a well-known scientific driving test that measures standard deviation of vehicle position (SDLP), an index of lane weaving, swerving and overcorrecting. Participants were assessed at 40 minutes and four hours after inhaling vaporized cannabis.

All in all, the researchers found that cannabis containing CBD had no effect on driving, whereas that containing THC, or a mixture of CBD and THC mildly impaired driving 40 minutes after vaporization. After four hours, those who consumed THC had no impairment. 

"With cannabis laws changing globally, jurisdictions are grappling with the issue of cannabis-impaired driving. These results provide much-needed insights into the magnitude and duration of impairment caused by different types of cannabis and can help to guide road-safety policy not just in Australia but around the world," says Dr. Thomas Arkell, lead author of the study. 

"Studying the effects of cannabis on driving with such precision in a real-world context is incredibly important," says Professor Iain McGregor, Academic Director of the Lambert Initiative. "The results should reassure people using CBD-only products that they are most likely safe to drive while helping patients using THC-dominant products to understand the duration of impairment."

 

Sources: The University of SydneyJAMA

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
NOV 22, 2020
Cannabis Sciences
Public Believes CBD is Cure-All Despite Lack of Evidence
NOV 22, 2020
Public Believes CBD is Cure-All Despite Lack of Evidence
Many people think that cannabidiol (CBD), a non-psychoactive compound in cannabis, can reduce symptoms from various cond ...
JAN 14, 2021
Health & Medicine
Where There's Recreational Cannabis Junk Food Sales Are Higher
JAN 14, 2021
Where There's Recreational Cannabis Junk Food Sales Are Higher
In areas where recreational cannabis has been legalized, sales of “junk” foods such as ice cream, cookies an ...
FEB 11, 2021
Health & Medicine
Post-EVALI Investigation by Leafly Reveals Inadequate Cannabis Vape Controls
FEB 11, 2021
Post-EVALI Investigation by Leafly Reveals Inadequate Cannabis Vape Controls
Cannabis website Leafly has published the results of their probe into vape rules following the EVALI (e-cigarette or vap ...
FEB 12, 2021
Neuroscience
How Cannabis Affects Entrepreneurial Skills
FEB 12, 2021
How Cannabis Affects Entrepreneurial Skills
Entrepreneurs are often known for their blue sky thinking, but when idea creation happens by entrepreneurs who are also ...
FEB 18, 2021
Health & Medicine
Cannabinoids Show Promise in Skin Care
FEB 18, 2021
Cannabinoids Show Promise in Skin Care
Polish researchers have published a study that shows potential benefits of components of the cannabis family (cannabis a ...
MAR 17, 2021
Health & Medicine
CBD Inhibits Brain Changes that Initiate  Alzheimer's: Animal Study
MAR 17, 2021
CBD Inhibits Brain Changes that Initiate Alzheimer's: Animal Study
Cannabidiol, or CBD — the main non-psychoactive ingredient in cannabis — may inhibit some triggers for Alzhe ...
Loading Comments...